In recent trading session, Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) saw 2.23 million shares changing hands at last check today with its beta currently measuring 1.45. Company’s recent per share price level of $0.28 trading at -$0.01 or -3.94% at last check today assigns it a market valuation of $0.07M. That most recent trading price of BDRX’s stock is at a discount of -3046.43% from its 52-week high price of $8.81 and is indicating a premium of 7.14% from its 52-week low price of $0.26. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.21 million shares which gives us an average trading volume of 1.44 million if we extend that period to 3-months.
Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information
Upright in the red during last session for losing -3.94%, in the last five days BDRX remained trading in the red while hitting it’s week-highest on Friday, 09/20/24 when the stock touched $0.28 price level, adding 26.41% to its value on the day. Biodexa Pharmaceuticals Plc ADR’s shares saw a change of -89.55% in year-to-date performance and have moved -23.47% in past 5-day. Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) showed a performance of -52.53% in past 30-days. Number of shares sold short was 81383.0 shares which calculate 0.46 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Biodexa Pharmaceuticals Plc ADR (BDRX) estimates and forecasts
Statistics highlight that Biodexa Pharmaceuticals Plc ADR is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -67.39% of value to its shares in past 6 months, showing an annual growth rate of 98.79% while that of industry is 17.50. Apart from that, the company came raising its revenue forecast for fiscal year 2024.
1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 240k for the same. And 1 analysts are in estimates of company making revenue of 370k in the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 86.34% during past 5 years.
